The future of patient recruitment: Building a more connected ecosystem

Clinical trial recruitment is undergoing a fundamental shift. Increasing protocol complexity, growing operational demands, and rising patient expectations are changing how organizations identify, engage, and retain participants. 

Nearly one in four sites declined a trial due to protocol complexity, while endpoints and procedures have increased 29% and 61%, respectively, over the past decade, according to the Tufts Center for the Study of Drug Development.¹ 

These growing demands are forcing the industry to rethink recruitment, shifting from a study-specific activity to a long-term strategy built on community engagement, patient education, operational flexibility, and stronger collaboration among sites, sponsors, and CROs.

Recruitment is not one-size-fits-all

Every site serves a unique patient population, shaped by local demographics, healthcare access, cultural considerations, and community needs. What works in one geographic region or community may not resonate in another.

As trusted members of their communities, sites often have a closer relationship with and a deep understanding of the patients they serve, including how they prefer to receive information and what barriers may prevent participation in research. They also understand that successful recruitment is a long-term effort that extends beyond the needs of any single study.

Effective recruitment strategies often combine multiple approaches, including physician referrals, community outreach, patient databases, digital campaigns, educational initiatives, and local advertising. The most successful programs account for the unique needs of individual sites, with sponsors and CROs providing the materials, resources, and support needed to fill local gaps and strengthen outreach efforts. Providing adaptable recruitment materials, diverse imagery, and locally relevant messaging can also help sites connect more effectively with potential participants.

Supporting sites for recruitment success

Many sites invest significant time, effort, and resources into building awareness of clinical research long before a specific study launches.

Community education programs, disease awareness initiatives, local events, and patient outreach efforts all help create trust and interest in research participation. Connecting sites with patient advocacy groups can further strengthen these efforts by expanding community reach, increasing disease awareness, and helping build trusted relationships with potential participants. Yet these activities are rarely tied to a single protocol and are often not fully funded through individual study budgets. As a result, sites frequently carry the responsibility of maintaining long-term relationships with patients and communities.

Sponsors and CROs have an opportunity to strengthen recruitment outcomes by partnering with sites earlier in the study planning process. Engaging sites during recruitment strategy development and incorporating their insights into outreach materials, communication approaches, and community engagement plans can help create recruitment programs that are more effective, efficient, and relevant to patients.

Greater flexibility from sponsors and CROs in supporting and reimbursing community awareness and engagement activities can also help sustain the long-term investments sites make to build relationships with patients and communities.

Patient-centric recruitment goes beyond awareness

Recruitment does not end when patients learn about a clinical trial. Once patients learn about a study, they need clear information, practical support, and confidence that participation is right for them.

Patient-centric recruitment strategies focus on reducing barriers and making participation more accessible. Flexible visit schedules, transportation assistance, virtual engagement options, and other supportive services can help patients navigate the realities of participating in a clinical trial.

Meeting patients where they are is no longer optional. It is essential to improving both enrollment and retention and reducing the patient burden.

The growing role of AI

Beyond analyzing electronic health records (EHRs) and electronic medical records (EMRs) to identify potentially eligible patients, newer AI tools have the potential to match patients to studies based on complex eligibility criteria, predict which patients are most likely to enroll or remain engaged, and identify potential recruitment challenges earlier in the process. 

AI is also enhancing patient engagement through personalized communications, appointment reminders, scheduling support, virtual assistants, and proactive follow-up that can help keep participants informed and connected throughout their clinical trial journey. By automating routine administrative activities, AI can reduce burden on site staff and allow them to spend more time supporting patients directly. 

However, technology should complement, not replace, the trusted relationships that drive successful clinical research. Sites remain uniquely positioned to educate, guide, and support patients through complex healthcare decisions. While AI can improve efficiency and expand reach, trust, empathy, and human connection remain essential to enrollment, engagement, and long-term retention.

Looking ahead

The future of patient recruitment will depend on stronger collaboration among sponsors, CROs, and sites, combined with technologies that make research more accessible and personalized. While AI can help identify and engage participants more efficiently, sites will remain at the center of the recruitment journey as trusted guides within their communities. By combining innovation and partnership, the industry can help more patients access clinical research and accelerate the delivery of new therapies.

 

Start a conversation

Resources

1. Tufts Center for the Study of Drug Development, Impact Report, January 2026.

Return to Insights Center